Governor Andrew Cuomo announced on Thursday that he would conduct his own review of the coronavirus vaccine approved or approved by the federal government due to concerns over the politicization of the approval process.
Democrat Kuomo, who has repeatedly criticized President Donald Trump and his Republican response to the coronavirus pandemic, told reporters at a press conference a review committee to advise the state on vaccine safety. He said he was planning to form.
“Frankly, I’m not going to trust the federal opinion,” Cuomo said. “New York The state conducts its own review when the federal government completes the review and states that it is safe. “
A U.S. Food and Drug Administration spokeswoman declined to comment on the governor’s remarks. On Wednesday, FDA Commissioner Steven Hahn told the US Senate Commission that authorities would only approve safe and effective vaccines.
The Centers for Disease Control and Prevention (CDC) declined to comment, saying it was a question to the US Department of Health and Human Services (HHS). The department did not immediately respond to the request for comment.
“The state’s choice to independently review the safety and efficacy of our products is a daunting sign,” said Dr. Paul Ofit, an infectious disease expert at the University of Pennsylvania and the Philadelphia Children’s Hospital. With comments emailed to Reuters.
A recent statement by Trump and his Secretary of Health and Human Services regarding the approval of the COVID-19 vaccine, which is currently in the late stages of testing, raises concerns among health experts that the FDA’s decision may be politically independent. Is causing it.
“The way the federal government processes vaccines now has serious questions about whether vaccines have been politicized,” Cuomo said.
According to authorities, CDC, Pentagon, and HHS officials are expected to assign approved vaccines to states and handle most distributions.
Cuomo said a state expert committee would develop an approved vaccine distribution and implementation plan to determine who would be vaccinated first.
While all US states are expected to plan vaccine distributions, conducting an independent safety review would be a very rare move.
President Trump has reiterated that the COVID-19 vaccine could be distributed for the November 3 presidential election.
Mr. Trump said Wednesday that he may not approve the new, stricter FDA standards for urgent approval of the COVID-19 vaccine, and said such a proposal was political.
Washington post The FDA reported Tuesday that it would issue guidance to increase transparency and public confidence, fearing that it might be under pressure to rush the vaccine.
“We are looking at it, and it must be approved by the White House. When asked about the report, Trump said at a White House press conference.
For more information on the coronavirus, please visit: longislandpress.com/coronavirus